Schering-Plough
Moraxella Bovis Bacterin
Contains chemically-inactivated cultures of Moraxella bovis isolates referred to by Schering-Plough as Strains Epp 63, Fla 64 and SAH 38 in an oil emulsion adjuvant.
For use in healthy cattle to aid in the prevention of pinkeye associated with infection by Moraxella bovis strains expressing pili similar to those expressed by isolates referred to by Schering-Plough as Strains Epp 63, Fla 64 and SAH 38.
ADMINISTRATION: Shake well before use. The vaccine may be warmed to room temperature prior to injection. Inject 2 mL subcutaneously or intramuscularly INTO THE NECK 3 to 6 weeks prior to onset of pinkeye season. Annual revaccination is recommended.
CAUTION: For veterinary use only. Use may occasionally lead to development of granulomas which may persist for several weeks. Store at 2°-7°C (35°-45°F). Do not freeze. Use the entire contents when first opened. Do not vaccinate within 60 days of slaughter. Transient local reaction may occur at the injection site. If anaphylaxis occurs administer epinephrine. Hypersensitivity reactions may occur with a biological product and can cause temporary reduced milk production in lactating cattle.
PRESERVATIVE: Gentamicin.
WARNING: Extreme caution should be used when injecting any oil emulsion vaccine to avoid injecting your own finger or hand. Accidental injection can cause serious local reaction. Contact a physician immediately if accidental injection occurs.
U.S. Veterinary License No. 165A
Schering-Plough Animal Health Corp., Omaha, Nebraska 68103, USA
1 800 211-3573 (USA)
Copyright © 1990, 1992, 1995
Schering-Plough Animal Health Corp.
All rights reserved.
|
|
|
NDC- |
|
|
20 mL |
10 Doses |
0061-0969-01 |
P13728-15 |
|
100 mL |
50 Doses |
0061-0969-02 |
P13729-14 |
NAC No.: 10471532